Patiño P - Search Results

1

Ischemic brain injury: New insights on the protective role of melatonin.

Ramos E, Patiño P, Reiter RJ, Gil-Martín E, Marco-Contelles J, Parada E, de Los Rios C, Romero A, Egea J. Ramos E, et al. Among authors: patino p. Free Radic Biol Med. 2017 Mar;104:32-53. doi: 10.1016/j.freeradbiomed.2017.01.005. Epub 2017 Jan 6. Free Radic Biol Med. 2017. PMID: 28065781 Review.

2

Melatonin: A hypothesis for Kawasaki disease treatment.

Ramos E, Patiño P, Reiter RJ, Gil-Martín E, López-Muñoz F, Romero A. Ramos E, et al. Among authors: patino p. Med Hypotheses. 2018 Oct;119:6-10. doi: 10.1016/j.mehy.2018.07.010. Epub 2018 Jul 17. Med Hypotheses. 2018. PMID: 30122493

3

Melatonin protects against oxygen and glucose deprivation by decreasing extracellular glutamate and Nox-derived ROS in rat hippocampal slices.

Patiño P, Parada E, Farré-Alins V, Molz S, Cacabelos R, Marco-Contelles J, López MG, Tasca CI, Ramos E, Romero A, Egea J. Patiño P, et al. Neurotoxicology. 2016 Dec;57:61-68. doi: 10.1016/j.neuro.2016.09.002. Epub 2016 Sep 9. Neurotoxicology. 2016. PMID: 27620136

4

Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

Romero A, Ramos E, Patiño P, Oset-Gasque MJ, López-Muñoz F, Marco-Contelles J, Ayuso MR, Alcázar A. Romero A, et al. Among authors: patino p. Front Aging Neurosci. 2016 Nov 23;8:281. doi: 10.3389/fnagi.2016.00281. eCollection 2016. Front Aging Neurosci. 2016. PMID: 27932976 Free PMC article.

5

Corrigendum: Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

Romero A, Ramos E, Patiño P, Oset-Gasque MJ, López-Muñoz F, Marco-Contelles J, Ayuso MI, Alcázar A. Romero A, et al. Among authors: patino p. Front Aging Neurosci. 2017 May 29;9:159. doi: 10.3389/fnagi.2017.00159. eCollection 2017. Front Aging Neurosci. 2017. PMID: 28572769 Free PMC article.

6

Glutamate-dependent long-term presynaptic changes in corticostriatal excitability.

Garcia-Munoz M, Patino P, Masliah E, Young SJ, Groves PM. Garcia-Munoz M, et al. Among authors: patino p. Neuroscience. 1996 Jul;73(1):109-19. doi: 10.1016/0306-4522(96)00007-3. Neuroscience. 1996. PMID: 8783235

7

Effects of nicotine on dopaminergic nigrostriatal axons requires stimulation of presynaptic glutamatergic receptors.

Garcia-Munoz M, Patino P, Young SJ, Groves PM. Garcia-Munoz M, et al. Among authors: patino p. J Pharmacol Exp Ther. 1996 Jun;277(3):1685-93. J Pharmacol Exp Ther. 1996. PMID: 8667239

8

Amphetamine-induced changes in nigrostriatal terminal excitability are modified following repeated amphetamine pretreatment.

Garcia-Munoz M, Segal DS, Patino P, Young SJ, Kuczenski R, Groves PM. Garcia-Munoz M, et al. Among authors: patino p. Brain Res. 1996 May 13;720(1-2):131-8. doi: 10.1016/0006-8993(96)00161-8. Brain Res. 1996. PMID: 8782905

9

Lesions in the dentate hilum and CA2/CA3 regions of the rat hippocampus produce cognitive deficits that correlate with site-specific glial activation.

Samuel W, Masliah E, Brush DE, Garcia-Munoz M, Patino P, Young SJ, Groves PM. Samuel W, et al. Among authors: patino p. Neurobiol Learn Mem. 1997 Sep;68(2):103-16. doi: 10.1006/nlme.1997.3789. Neurobiol Learn Mem. 1997. PMID: 9322254

10

The anatomical substrate of the turning behaviour seen after lesions in the nigrostriatal dopamine system.

Garcia-Munoz M, Patino P, Wright AJ, Arbuthnott GW. Garcia-Munoz M, et al. Among authors: patino p. Neuroscience. 1983 Jan;8(1):87-95. doi: 10.1016/0306-4522(83)90027-1. Neuroscience. 1983. PMID: 6300729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

71 results

Search Page